Cargando…

Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme

Detalles Bibliográficos
Autores principales:	Wolf, Amparo, Agnihotri, Sameer, Guha, Abhijit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205170/ https://www.ncbi.nlm.nih.gov/pubmed/30410682 http://dx.doi.org/10.18632/oncotarget.26219

Ejemplares similares

Targeting Metabolic Remodeling in Glioblastoma Multiforme
por: Wolf, Amparo, et al.
Publicado: (2010)

Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
por: Wolf, Amparo, et al.
Publicado: (2011)

Erratum: Rare case of conus medullaris glioblastoma multiforme in a teenager
Publicado: (2017)

Erratum to: Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme
por: Galldiks, Norbert, et al.
Publicado: (2010)

Erratum to: Targeting the TREM1-positive myeloid microenvironment in glioblastoma
Publicado: (2023)

Erratum: Lee, H.H., et al. Histone 2A Family Member J Drives Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Multiforme. Cancers 2020, 12, 98
por: Lee, Hsun-Hua, et al.
Publicado: (2020)

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
por: Gallego, Oscar, et al.
Publicado: (2014)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Erratum for “Dynamic Remodeling of Microbial Biofilms by Functionally Distinct Exopolysaccharides”
por: Chew, Su Chuen, et al.
Publicado: (2015)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme
por: DeSouza, Leroi V, et al.
Publicado: (2013)

Erratum to “Pro/Anti-Inflammatory Cytokine Imbalance in Postischemic Left Ventricular Remodeling”
por: Pasqui, Anna Laura, et al.
Publicado: (2010)

Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
por: Addeo, Raffaele, et al.
Publicado: (2010)

Erratum to: the ER stress inducer DMC enhances TRAIL-induced apoptosis in glioblastoma
por: van Roosmalen, Ingrid AM, et al.
Publicado: (2014)

Erratum to liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization
Publicado: (2023)

Erratum to: Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver
por: Liu, Shuang, et al.
Publicado: (2016)

Targeting cellular pathways in glioblastoma multiforme
por: Pearson, Joshua R D, et al.
Publicado: (2017)

Drug target ranking for glioblastoma multiforme
por: Saraf, Radhika, et al.
Publicado: (2021)

Erratum to: Metabolic regulation by p53
por: Maddocks, Oliver D. K., et al.
Publicado: (2011)

Erratum: Metabolic syndrome and the hepatorenal reflex
Publicado: (2017)

Erratum to: MIIP remodels Rac1-mediated cytoskeleton structure in suppression of endometrial cancer metastasis
por: Wang, Yingmei, et al.
Publicado: (2017)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Erratum to: Factors associated with a higher rate of distant failure after primary treatment for glioblastoma
por: Tejada, Sonia, et al.
Publicado: (2013)

Erratum to: A Novel Case of Solitary Cerebral Toxoplasmosis Mimicking Glioblastoma as the First Presentation of HIV
por: León Ruiz, Moisés
Publicado: (2016)

Erratum to: Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometry
por: Yoon, Hye-Ran
Publicado: (2015)

ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
por: Garcia, Joseph H, et al.
Publicado: (2021)

A role for activated Cdc42 in glioblastoma multiforme invasion
por: Okura, Hidehiro, et al.
Publicado: (2016)

Erratum: Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition
Publicado: (2019)

Erratum to: The Role of CARD9 in Metabolic Diseases
por: Tian, Cheng, et al.
Publicado: (2020)

The role of metabolic therapy in treating glioblastoma multiforme
por: Maroon, Joseph C., et al.
Publicado: (2015)

Erratum to “Hox Targets and Cellular Functions”
por: Sánchez-Herrero, Ernesto
Publicado: (2014)

Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Chen, Qi, et al.
Publicado: (2019)

Erratum to: Iron metabolism and iron supplementation in cancer patients
por: Ludwig, Heinz, et al.
Publicado: (2015)

Current Trends in Targeted Therapies for Glioblastoma Multiforme
por: Ohka, Fumiharu, et al.
Publicado: (2012)

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019)

ProNGF Expression and Targeting in Glioblastoma Multiforme
por: Marsland, Mark, et al.
Publicado: (2023)

Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene
por: Chakraborty, Abhijit, et al.
Publicado: (2014)

Erratum: Multi-Tissue DNA Methylation Remodeling at Mitochondrial Quality Control Genes According to Diet in Rat Aging Models
por: D’Aquila, Patrizia, et al.
Publicado: (2020)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis: Erratum
Publicado: (2017)

Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis
por: Alnahhas, Iyad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vf067h7ud3grkp3kjnakofa1er